Cushman & Wakefield Ltd.
No SEC Form 4 filings for $CWK in the last 30 days.
Cushman & Wakefield plc reported record Q2 2026 total revenue and the lowest gross debt balance in its history, citing organic growth and leasing gains. It raised 2026 annual adjusted EPS growth to 18% to 23% and expects revenue growth at the mid-to-high end of 6% to 8%. Net leverage fell to 3x. Management plans to redeem $150m 2028 notes by mid-2027.
Cushman & Wakefield (C&W) reported Q2 2026 revenue up 11% to $2.8B and adjusted diluted EPS up 17% to 35 cents, beating revenue estimates by 4.6% but missing EPS expectations. The company raised full-year adjusted EPS growth guidance to 18% to 23% and cited record leasing and services revenue, with leasing revenue up 27% to $628.5M.
Cushman & Wakefield (NYSE: CWK) reported Q2 CY2026 revenue of $2.76 billion, up 11.2% year on year and 3.4% above Wall Street estimates. Non-GAAP adjusted EPS was $0.35, in line with consensus. Analysts project revenue growth of 5.8% over the next 12 months and full-year EPS rising from $1.33 to $1.55.
Over the past 7 days, alphai's AI scored 4 news stories mentioning CWK (Cushman & Wakefield Ltd.). Coverage has skewed bullish: 4 bullish, 0 neutral, and 0 bearish.
Recent CWK coverage spans earnings, market movers and sector analysis.
Higher 2026 EPS and revenue growth targets, plus deleveraging via planned redemption of $150m 2028 notes, should support near-term multiple and credit sentiment.
Guidance raise and record Q2 metrics suggest improving fundamentals and could support upward revisions to 2026 estimates.
The beat plus stable margins supports near-term downside protection, but the article flags decelerating forward revenue growth.
Guidance raise plus strong leasing and services growth suggests improved earnings trajectory and potentially supports near-term multiple expansion.
Fundamentals improved via volume and input-cost pass-through, but the stock reaction suggests investors wanted different margins or demand signals.
alphai scores every news story that mentions CWK with an AI model for sentiment and relevance, and aggregates insider trades from Cushman & Wakefield Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cushman & Wakefield plc reported record Q2 2026 total revenue and the lowest gross debt balance in its history, citing organic growth and leasing gains. It raised 2026 annual adjusted EPS growth to 18% to 23% and expects revenue growth at the mid-to-high end of 6% to 8%. Net leverage fell to 3x. Management plans to redeem $150m 2028 notes by mid-2027.
6 min readCushman & Wakefield (C&W) reported Q2 2026 revenue up 11% to $2.8B and adjusted diluted EPS up 17% to 35 cents, beating revenue estimates by 4.6% but missing EPS expectations. The company raised full-year adjusted EPS growth guidance to 18% to 23% and cited record leasing and services revenue, with leasing revenue up 27% to $628.5M.
3 min readCushman & Wakefield (NYSE: CWK) reported Q2 CY2026 revenue of $2.76 billion, up 11.2% year on year and 3.4% above Wall Street estimates. Non-GAAP adjusted EPS was $0.35, in line with consensus. Analysts project revenue growth of 5.8% over the next 12 months and full-year EPS rising from $1.33 to $1.55.
4 min readCushman & Wakefield Ltd. (CWK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cwk-ex991q22026.htm EX-99.1 Document Exhibit 99.1 For Immediate Release Cushman & Wakefield Reports Financial Results for the Second Quarter 2026 Strong Leasing revenue growth of 27% (27% in local currency) Continued momentum in Services revenue growth, up 8% (7% in loc
6 min readAstraZeneca (AZN) reassured investors after the failed Wainua phase 3 trial, reaffirming mid-to-high single digit full-year revenue growth. It reported $4bn R&D spend and total sales up 6% at constant currency, with Imfinzi sales above $2bn. Vodafone (VOD) shares rose on guidance for FY27 adjusted EBITDA €13bn to €13.3bn. Other updates covered Cranswick (CWK), DCC Energy (DCC), Serica Energy (SQZ), Pharos (PHAR), and Pinewood Technologies (PINE) takeover bids.
7 min readCushman & Wakefield Ltd, NYSE-listed, said its US Office MarketBeat shows national office vacancy fell year-on-year for a second straight quarter and demand hit a six-year high on a four-quarter rolling basis. Vacancy dropped 10 bps to 20.1%. Vacant sublease space fell 15.4% to 95.6M sq ft; completions fell 24% to 15.6M sq ft over four quarters.
4 min readBarclays initiated coverage of UK food producer Cranswick (CWK) with an “overweight” rating and a 63.80p price target, citing capital discipline, health/protein demand tailwinds and growth in at-home eating. It forecasts 6% pre-tax profit CAGR (FY2026-29), 5% revenue and 6% EPS growth, plus ~2% dividend yield. Risks include food safety, margin pressure and competition.
4 min readStocks including Cushman & Wakefield (CWK, +2.7%) and RE/MAX (RMAX, +3%) rose after an Iran peace deal lowered Treasury yields, which can ease mortgage rates. The 10-year yield fell to 4.41% (lowest since mid-May) as oil dropped and inflation expectations repriced. The article links the move to rate-sensitive housing demand and notes RMAX is up 27.1% YTD but 16.7% below its 52-week high.
7 min readCushman & Wakefield Ltd. (CWK) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 exhibit101-june152026.htm EX-10.1 Document Exhibit 10.1 Execution Version AMENDMENT NO. 14 TO THE CREDIT AGREEMENT AMENDMENT NO. 14 to the Credit Agreement (as defined below), dated as of June 12, 2026 (this “ Amendment ”), among Cushman & Wakefield U.S. Borrower, LLC,
3 min readRobinson Nathaniel (See Remarks) sold 24,828 shares of Cushman & Wakefield Ltd. (CWK) at $13.25 ($0.33M total) on 2026-06-04.
2 min read
